Epidermolytic hyperkeratosis type PS-1 caused by aberrant splicing of KRT1

Clinical and Experimental Dermatology

Volumn 30, Issue 1, 2005, Pages 64-67

  Tal, O ^a   Bergman, R ^a   Alcalay, J ^b   Indelman, M ^a   Sprecher, Eli ^a  

^a RAMBAM MEDICAL CENTER   (Israel)

^b ASSUTA MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

KERATIN; KERATIN TYPE 1; MESSENGER RNA; UNCLASSIFIED DRUG;

ARTICLE; AUTOSOMAL DOMINANT DISORDER; GENE; GENE DELETION; GENE MUTATION; HISTOPATHOLOGY; HUMAN; HYPERKERATOSIS; KERATOSIS PALMOPLANTARIS; KRT1 GENE; LYMPHOCYTE; PHENOTYPE; PRIORITY JOURNAL; RNA SPLICING; SEQUENCE ANALYSIS;

ADULT; DNA MUTATIONAL ANALYSIS; GENE DELETION; HUMANS; HYPERKERATOSIS, EPIDERMOLYTIC; KERATIN-1; KERATINS; KERATODERMA, PALMOPLANTAR; MUTATION; RNA SPLICING;

EID: 13244259262     PISSN: 03076938     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2230.2004.01661.x     Document Type: Article

References (11)

1. Kimyai-Asadi A, Kotcher LB, Jih MH. The molecular basis of hereditary palmoplantar keretodermas. J Am Acad Dermatol 2002; 47: 327-43.
2. Chipev CC, Korge BP, Markova N et al. A leucine-proline mutation in the H1 subdomain of keratin 1 causes epidermolytic hyperkeratosis. Cell 1992; 70: 821-8.
3. Rothnagel JA, Dominey AM, Dempsey LD et al. Mutations in the rod domains of keratin 1 and 10 in epidermolytic hyperkeratosis. Science 1992; 257: 1128-30.
4. DiGiovanna JJ, Bale SJ. Clinical heterogeneity in epidermolytic hyperkeratosis. Arch Dermatol 1994; 130: 1026-35.
5. Virtanen M, Gedde-Dahl T, Mork NJ et al. Phenotypic/genotypic correlations in patients with epidermolytic hyperkeratosis and the effects of retinoid therapy on keratin expression. Acta Derm Venereol 2001; 81: 16370.
6. Whittock NV, Eady RA, McGrath JA. Genomic organization and amplification of the human epidermal type II keratin genes K1 and K5. Biochem Biophys Res Commun 2000; 274: 149-52.
7. Kirfel J, Magin TM, Reichelt J. Keratins: a structural scaffold with emerging functions. Cell Mol Life Sci 2003; 60: 56-71.
8. Porter RM, Lane EB. Phenotypes, genotypes and their contribution to understanding keratin function. Trends Genet 2003; 19: 278-85.
9. Hatsell S, Eady RA, Wennerstrand L et al. Novel splice site mutation in keratin 1 underlies mild epidermolytic palmoplantar keratoderma in three kindreds. J Invest Dermatol 2001; 116: 606-9.
10. Terron-Kwiatkowski A, Paller AS, Compton J et al. Two cases of primarily palmoplantar keratoderma associated with novel mutations in keratin 1. J Invest Dermatol 2002; 119: 966-71.
11. Virtanen M, Smith SK, Gedde-Dahl T et al. Splice site and deletion mutations in keratin (KRT1 and KRT10) genes: unusual phenotypic alterations in Scandinavian patients with epidermolytic hyperkeratosis. J Invest Dermatol 2003; 121: 1013-20.